Hooman Madyoon

993 total citations
21 papers, 647 citations indexed

About

Hooman Madyoon is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, Hooman Madyoon has authored 21 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Nephrology. Recurrent topics in Hooman Madyoon's work include Cardiac Imaging and Diagnostics (7 papers), Coronary Interventions and Diagnostics (6 papers) and Acute Kidney Injury Research (6 papers). Hooman Madyoon is often cited by papers focused on Cardiac Imaging and Diagnostics (7 papers), Coronary Interventions and Diagnostics (6 papers) and Acute Kidney Injury Research (6 papers). Hooman Madyoon collaborates with scholars based in United States, Canada and Germany. Hooman Madyoon's co-authors include Norman E. Lepor, Andrew Wang, Gregg W. Stone, Melissa Stevens, Norman E. Lepor, Gary L. Schaer, William W. O’Neill, Robert L. Wilensky, James A. Tumlin and Patrick Murray and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Hooman Madyoon

21 papers receiving 628 citations

Peers

Hooman Madyoon

NEPHR

SURGE

RNMI

CCM

PRM

Jules Comin Australia

Vincent van Ommen Netherlands

Christian Mueller Germany

Douglas C. Westveer United States

Giovanni Teruzzi Italy

K. Levorstad Norway

Curtis W. Bakal United States

Sue Apple United States

Alice Ohanessian France

Alok Agrawal United States

Jules Comin Australia

Hooman Madyoon

202 ×0.6

NEPHR

247 ×1.3

SURGE

93 ×0.5

RNMI

83 ×0.5

CCM

103 ×0.7

PRM

Citations per year, relative to Hooman Madyoon Hooman Madyoon (= 1×) peers Jules Comin

Countries citing papers authored by Hooman Madyoon

Since Specialization

Citations

This map shows the geographic impact of Hooman Madyoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hooman Madyoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hooman Madyoon more than expected).

Fields of papers citing papers by Hooman Madyoon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hooman Madyoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hooman Madyoon. The network helps show where Hooman Madyoon may publish in the future.

Co-authorship network of co-authors of Hooman Madyoon

This figure shows the co-authorship network connecting the top 25 collaborators of Hooman Madyoon. A scholar is included among the top collaborators of Hooman Madyoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hooman Madyoon. Hooman Madyoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weinberg, Aaron S., Suhail Dohad, Danny Ramzy, Hooman Madyoon, & Victor F. Tapson. (2016). Clot Extraction With the FlowTriever Device in Acute Massive Pulmonary Embolism. Journal of Intensive Care Medicine. 31(10). 676–679. 14 indexed citations

Madyoon, Hooman & Norman E. Lepor. (2013). Venous Disease: The Missing Link in Cardiovascular Medicine. Reviews in Cardiovascular Medicine. 14(1). 7–19. 1 indexed citations

Lepor, Norman E. & Hooman Madyoon. (2009). Antiseptic Skin Agents for Percutaneous Procedures. Reviews in Cardiovascular Medicine. 10(4). 187–193. 5 indexed citations

Lepor, Norman E., Hooman Madyoon, & Gerald Friede. (2008). Priceless clinical pearls in the performance of cardiac CT.. PubMed. 9 Suppl 1. S3–13. 2 indexed citations

Topaz, On, Douglas G. Ebersole, Johannes B. Dahm, et al.. (2007). Excimer laser in myocardial infarction: a comparison between STEMI patients with established Q-wave versus patients with non-STEMI (non-Q). Lasers in Medical Science. 23(1). 1–10. 9 indexed citations

Cheng, Victor, et al.. (2007). Presence and Severity of Noncalcified Coronary Plaque on 64-Slice Computed Tomographic Coronary Angiography in Patients With Zero and Low Coronary Artery Calcium. The American Journal of Cardiology. 99(9). 1183–1186. 95 indexed citations

Teirstein, Paul S., Matthew J. Price, Vandana Mathur, et al.. (2006). Differential Effects Between Intravenous and Targeted Renal Delivery of Fenoldopam on Renal Function and Blood Pressure in Patients Undergoing Cardiac Catheterization. The American Journal of Cardiology. 97(7). 1076–1081. 32 indexed citations

Lepor, Norman E., Hooman Madyoon, & Gerald Friede. (2005). The emerging use of 16- and 64-slice computed tomography coronary angiography in clinical cardiovascular practice.. PubMed. 6(1). 47–53. 8 indexed citations

Ebersole, Douglas G., Johannes B. Dahm, Tony Das, et al.. (2004). Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction.. PubMed. 16(4). 177–80. 21 indexed citations

10.

Topaz, On, Douglas G. Ebersole, Tony Das, et al.. (2004). Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). The American Journal of Cardiology. 93(6). 694–701. 67 indexed citations

11.

Weisz, Giora, Jeffrey W. Moses, Jeffrey J. Popma, et al.. (2003). Do overlapping multiple sirolimus-eluting stents impact angiographic and clinical outcomes? Insights from the SIRIUS trial. Journal of the American College of Cardiology. 41(6). 33–33. 3 indexed citations

12.

Stone, Gregg W., P. R. McCullough, James A. Tumlin, et al.. (2003). A prospective, randomized placebo-controlled multicenter trial evaluating fenoldopam mesylate for the prevention of contrast induced nephropathy: The CONTRAST trial. Journal of the American College of Cardiology. 41(6). 83–84. 4 indexed citations

13.

Stone, Gregg W., Peter A. McCullough, James A. Tumlin, et al.. (2003). Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy. JAMA. 290(17). 2284–2284. 266 indexed citations

14.

Madyoon, Hooman, et al.. (2002). Unprotected Carotid Artery Stenting Compared to Carotid Endarterectomy in a Community Setting. Journal of Endovascular Therapy. 9(6). 803–809. 1 indexed citations

15.

Lepor, Norman E., Hooman Madyoon, & Dean J. Kereiakes. (2002). Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.. PubMed. 3 Suppl 5. S38–50. 8 indexed citations

16.

Madyoon, Hooman, et al.. (2001). Use of Fenoldopam for Prevention of Radiocontrast Nephropathy in the Cardiac Catheterization Laboratory: A Case Series. Journal of Interventional Cardiology. 14(2). 179–186. 10 indexed citations

17.

Madyoon, Hooman. (2001). Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.. PubMed. 2(1). 26–30. 8 indexed citations

18.

Madyoon, Hooman, et al.. (2001). Application of Excimer Laser Coronary Angioplasty (ELCA) in Bifurcation Lesions. Lasers in Medical Science. 16(2). 108–112. 4 indexed citations

19.

Madyoon, Hooman, et al.. (2001). Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients. Catheterization and Cardiovascular Interventions. 53(3). 341–345. 63 indexed citations

20.

Madyoon, Hooman, et al.. (2001). Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.. PubMed. 2 Suppl 1. S31–6. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact